Cargando…
Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families
Approximately 25% of hereditary breast cancer cases are associated with a strong familial history which can be explained by mutations in BRCA1 or BRCA2 and other lower penetrance genes. The remaining high-risk families could be classified as BRCAX (non-BRCA1/2) families. Gene expression involving al...
Autores principales: | Pouliot, Marie-Christine, Kothari, Charu, Joly-Beauparlant, Charles, Labrie, Yvan, Ouellette, Geneviève, Simard, Jacques, Droit, Arnaud, Durocher, Francine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667991/ https://www.ncbi.nlm.nih.gov/pubmed/29108258 http://dx.doi.org/10.18632/oncotarget.20219 |
Ejemplares similares
-
Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
por: Desjardins, Sylvie, et al.
Publicado: (2009) -
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
por: Antoniou, Antonis C, et al.
Publicado: (2006) -
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy
por: Kothari, Charu, et al.
Publicado: (2018) -
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018) -
BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
por: Waddell, Nic, et al.
Publicado: (2008)